Cargando…
Corrigendum to “Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway” [Redox Biol. 52 (2022) 102288]
Autores principales: | Cai, Chen, Guo, Zhongzhou, Chang, Xing, Li, Ziying, Wu, Feng, He, Jing, Cao, Tiantian, Wang, Kangrong, Shi, Nengxian, Zhou, Hao, Toan, Sam, Muid, David, Tan, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257208/ https://www.ncbi.nlm.nih.gov/pubmed/37202250 http://dx.doi.org/10.1016/j.redox.2023.102738 |
Ejemplares similares
-
Empagliflozin attenuates cardiac microvascular ischemia/reperfusion through activating the AMPKα1/ULK1/FUNDC1/mitophagy pathway
por: Cai, Chen, et al.
Publicado: (2022) -
Vaspin Attenuates Atrial Abnormalities by Promoting ULK1/FUNDC1-Mediated Mitophagy
por: Zhu, Yanmin, et al.
Publicado: (2022) -
NTRK1 knockdown induces mouse cognitive impairment and hippocampal neuronal damage through mitophagy suppression via inactivating the AMPK/ULK1/FUNDC1 pathway
por: Yang, Kai, et al.
Publicado: (2023) -
Empagliflozin activates Wnt/β-catenin to stimulate FUNDC1-dependent mitochondrial quality surveillance against type-3 cardiorenal syndrome
por: Cai, Chen, et al.
Publicado: (2022) -
The Emerging Role of FUNDC1-Mediated Mitophagy in Cardiovascular Diseases
por: Liu, Lei, et al.
Publicado: (2021)